Data / Form D filings / Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc.: Form D filings
Garuda Therapeutics, Inc., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on October 31, 2024, reports $47.7 million sold of an offering with no set size to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 215 First Street, Suite 340-350, Cambridge, MA, 02142
- Phone
- (617) 851-4586
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1884363
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | New notice | Indefinite | $47,709,955 | 16 | Oct 17, 2024 | sec.gov | |
| Feb 3, 2023 | New notice | $62,898,094 | $62,124,935 | $773,159 | 13 | Jan 23, 2023 | sec.gov |
| Sep 24, 2021 | New notice | $71,790,005 | $48,123,334 | $23,666,671 | 23 | Sep 9, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Geoff Meyerson | Director | |
| Raymond Kelleher | Director | |
| Eric Aguiar | Director | |
| Steve Liapis | Director | |
| Rahul Singhvi | Director | |
| David Kirske | Executive Officer | |
| Carl Gordon | Director | |
| Adam Craig | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Garuda Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.